Overview

The second edition of an invaluable reference for the pulmonary hypertension specialist which should be found on the shelf of every cardiac, pulmonary and intensive care unit as an excellent resource for both clinicians and scientists.

Full Product Details

Author:   Andrew J. Peacock ,  L.J. Rubin
Publisher:   Taylor & Francis Ltd
Imprint:   Hodder Arnold
Edition:   2nd New edition
Dimensions:   Width: 20.20cm , Height: 3.80cm , Length: 27.00cm
Weight:   1.882kg
ISBN:  

9780340807828

ISBN 10:   0340807822
Pages:   672
Publication Date:   25 June 2004
Audience:   General/trade ,  College/higher education ,  Professional and scholarly ,  General ,  Undergraduate
Replaced By:   9780340981924
Format:   Hardback
Publisher's Status:   Out of Print
Availability:   Out of stock  

Table of Contents

1. Functional structure of the pulmonary circulation. J Gil (New York) 2. Pulmonary vascular function. Robert Naeije (Brussels) 3. Pathology of pulmonary vascular disease. Rubin Tuder (John's Hopkins, USA) 4. Hypoxic pulmonary vasoconstriction and hypertension. Ken Weir (Minneapolis) and Andrea Olschewski (Giessen, Germany) 5. Pulmonary vascular re-modelling. Nick Morrell (Cambridge, U.K.) 6. Genetics. Heather Mortimer & Jane Morse 7. Clinical features. Andrew J Peacock (Glasgow) 8. Echocardiography. Adam Torbicki (Warsaw) 9. Imaging (including CXR, CT, MR and radionucleide). Richard Coulden (Cambridge) 10. Cardiac catheterization. Bertrum Groves & David Badesch (Denver, Colorado) 11. An integrated approach to the diagnosis of PHT (incl screening, when to biopsy, what imaging technique and when etc.). Michael McGoon (Mayo Clinic, U.S.A) 12. Classification and clinical features of PHT. Stuart Rich (Illinois, USA) 13. Pulmonary arterial hypertension 13.1 Pathobiology of pulmonary arterial hypertension. Norbert Voelkel (Denver, Colorado) 13.2 Diseases associated with pulmonary arterial hypertension 13.3 Treatment 13.3.1 Conventional medical therapies (incl anticoagulants, calcium channel antagonists, inotropic agents, diuretics, supplemental oxygen). Nazzareno Galie (Bologna, Italy) 13.3.2 Disease modifying therapies 13.3.2.1 Intravenous prostacyclin in pulmonary arterial hypertension. Victor Tapson (Duke, NC) 13.3.2.2 Inhaled iloprost. Horst Olschewski (Germany) 13.3.2.3 Oral and subcutaneous prostacyclin analogues.Vallerie McLaughlin (Chicago, U.S.A) 13.3.2.4 Inhaled nitric oxide. Joanna Pepke-Zaba and Keith MacNeil (Cambridge, UK) 13.3.2.5 Endothelin antagonistsRick Channick (La Jolla, U.S.A) 13.3.2.6 Novel medical approaches aEURO growth inhibitors.Marlene Rabinovitch (Toronto, Canada) 13.3.3 Surgical therapies 13.3.3.1 Transplantation. Paul Corris (Newcastle, U.K) 13.3.3.2 Atrial septostomy. Julio Sandoval (Mexico City) 13.3.4 An integrated approach to the treatment of PAHT. Gerald Simonneau (Paris) 14.1 Diagnosis and treatment of left heart disease. Simon Gibbs (London, UK) 14.2 Pulmonary venous occlusive disease. Charles Hales and Barbara Cockrill (Harvard, USA) 14.3 Hemangiomatosis. David Langleben (Montreal) 15.1 Pulmonary hypertension due to chronic hypoxic lung disease (incl COPD, interstitial lung disease, parenchymal disease). Emmanuel Weitzenblum (Strasbourg, France) 15.2 Pulmonary hypertension in sleep disorders and breathing. John Stradling (Oxford, U.K.) 15.3 An integrated approach to the treatment of pulmonary hypertension due to hypoxic lung disease (incl diuretics, oxygen, NO, other vasodilators etc) William MacNee (Edinburgh, Scotland) 16. Acute pulmonary thromboembolism 16.1 Diagnosis. Arnaud Perrier (Geneva, Switzerland) 16.2 Treatment. Sam Goldhaber (Harvard, USA) 17. Chronic thromboembolic pulmonary hypertension: pathophysiology, diagnosis and treatment including thromboendarterectomy. Peter Fedullo, William Auger & Stuart Jamieson (San Diego, U.S.A) 18. Pulmonary vascular tumors. Kim Kerr (San Diego, USA) 19. Primary pulmonary hypertension in children.Robyn Barst (New York) 20. Persistent pulmonary hypertension of the newborn: strategies in clinical management. Steve Abman (Denver, U.S.A.) 21. Effects of mechanical ventilation on the pulmonary circulation. Michael Pinsky (Pittsburgh) 22. Effects of lung injury on the pulmonary circulation. Tim Evans (London) 23. Pharmacological manipulation of the pulmonary circulation in critically ill patients. Jean-Louis Vincent (Brussels) 24. High altitude, high altitude pulmonary edema and the pulmonary circulation. Marco Maggiori (Switzerland) and Peter Bartsch (Heidelberg, Germany) 25. Pulmonary circulation in the underwater environment. Stephen Watt (Aberdeen, U.K.) 26. Fetal lung circulation. Jack Reeves, Steve Abman & Kurt Stenmark (Denver, Colorado) 27. Hepato-pulmonary syndrome Michael Krowka (Mayo, Rochester, USA) 28. Pulmonary arteriovenous malformations. Claire Shovlin (London, U.K.)

Reviews

This second edition of Pulmonary Circulation is timely...This book is at the vanguard of its type in the field of the pulmonary circulation, and it achieves the editors' ambitious goal of providing a balance between scientific review and clinically relevant, comprehensive guidelines for the busy practicing physician. -- New England Journal of Medicine, June 2005 20050601 The second edition of Pulmonary Circulation is long overdue! If you are interested in pulmonary hypertension, this is likley to be the most up-to-date complete text available and I would recommend owning a copy. -- Chronic Respiratory Disease Journal 20050501

Author Information

Andrew J Peacock is Professor of Medicine, Consultant Respiratory Physician and Director, Scottish Pulmonary Vascular Unit, Western Infirmary, Glasgow, UK Lewis J Rubin is Professor of Medicine and Director, Pulmonary Vascular Center at the University of California, San Diego School of Medicine, La Jolla, USA

Tab Content 6

Author Website:  

Countries Available

All regions